What is Bloomage BioTechnology Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Bloomage BioTechnology's Average Total Inventories for the quarter that ended in Mar. 2025 was ¥1,237 Mil. Bloomage BioTechnology's Revenue for the
three
months ended in Mar. 2025 was ¥1,078 Mil.
Bloomage BioTechnology's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 1.15.
Bloomage BioTechnology's Inventory-to-Revenue for the quarter that ended in Mar. 2025
increased
from Dec. 2024 (0.86) to Dec. 2024 (1.15)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Bloomage BioTechnology's Days Inventory for the
three
months ended in Mar. 2025 was 376.13.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bloomage BioTechnology's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.24.
Bloomage BioTechnology Inventory-to-Revenue Historical Data
The historical data trend for Bloomage BioTechnology's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bloomage BioTechnology's Inventory-to-Revenue
For the Specialty Chemicals subindustry, Bloomage BioTechnology's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bloomage BioTechnology's Inventory-to-Revenue Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bloomage BioTechnology's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Bloomage BioTechnology's Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bloomage BioTechnology's Inventory-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Bloomage BioTechnology's Days Inventory for the
three
months ended in Mar. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bloomage BioTechnology Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Bloomage BioTechnology's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:688363 has been successfully added to your 